Table 2.
Comparison of clinical and biochemical parameters of 211 participants in the study according to the time on follow-up in the ACKD unit.
| Variables | No follow-up ACKD unit ≤6 months (n = 122) | Follow-up ACKD unit >6 months (n = 89) | p-Value |
|---|---|---|---|
| Age (years) | 67.6 ± 14.5 | 72.7 ± 12.3 | 0.050 |
| Male n (%) | 83 (68.0) | 55 (61.7) | 0.381 |
| Female n (%) | 39 (31.9) | 34 (38.2) | |
| Living with a family n (%) | 60 (49.1) | 61 (68.5) | 0.600 |
| Active workers n (%) | 23 (18.8) | 30 (33.7) | 0.565 |
| University education n (%) | 33 (27.0) | 34 (38.2) | 0.970 |
| eGFR (mL/min/1.73 m2)* | 12.8 ± 3.7 | 15.2 ± 2.3 | <0.001 |
| CCI (points) CCI: ≤ 3 points n (%) CCI: >3 points n (%) |
6.3 ± 1.5 2 (1.6) 120 (98.3) |
7.09 ± 1.1 0 89 (100%) |
0.024 |
| DM n (%) | 28 (58.3) | 20 (41.6) | 0.991 |
| High blood pressure n (%) | 118 (96.7) | 86 (96.6) | 0.971 |
| s-Albumin (g/dl) | 3.7 ± 0.6 | 4.0 ± 0.4 | 0.002 |
| s-Prealbumin (mg/dl) | 27.5 ± 5.3 | 30.7 ± 4.1 | <0.001 |
| s-Transferrin (mg/dl) | 188.3 ± 50.3 | 217.0 ± 42.5 | <0.001 |
| s-CRP (mg/dl) | 0.8 ± 1.4 | 0.2 ± 0.3 | <0.001 |
| Hemoglobin (g/dl) | 10.9 ± 1.4 | 11.6 ± 0.9 | <0.001 |
| Total lymphocyte count (103/mm3) | 2,064 ± 0.4 | 1,995 ± 0.4 | 0.296 |
| PNI (points) | 37.9 ± 6.0 | 40.3 ± 4.4 | <0.001 |
ACKD, advanced chronic kidney disease. CCI, Charlson comorbidity index; PNI, prognostic nutritional index; s-CRP, C-reactive protein.
*
eGFR, estimated glomerular filtrate rate was measured by the 2021 CKD-EPI equation (25).